In contrast, breast tumors from DCA/Metformin-treated mice showed decreased mTORC1 signaling, reduced levels of p62, and decreased FLuc and GLuc expression (Fig. 6f), consistent with the depletion of T47DAR cells by metabolic drugs. The gene discussed is SQSTM1; the disease is breast neoplasm.